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Mannose-binding lectin deficiency in preterm neonates  
 
INTRODUCTION 
Mannose-binding lectin (MBL), also called 
mannose binding protein (MBP), is a calcium-
dependent serum protein that plays a role in the 
innate immune response by binding to 
carbohydrates on the surface of  a wide range of 
pathogens (viruses, bacteria, fungi, protozoa) where 
it can activate the complement system or act 
directly as an opsonin1.  
Circulating MBL concentrations and functional 
activity are correlated with common genetic 
variants in the MBL2 gene. Three single nucleotide 
polymorphisms (SNPs) in codons 52, 54 and 57 (D, 
B and C variants, respectively) of exon-1 lead to 
reduced functional plasma MBL concentrations2 . 
MBL deficiency arising from mutations and 
promoter polymorphisms in the MBL2 has been 
associated with increased risk, severity, and 
frequency of infections and autoimmunity3 . 
Neonates are prone to develop infections which 
are sometimes life-threatening, especially in 
premature patients admitted to the neonatal 
intensive care unit4. 
Neonatal MBL concentration increases during 
the first weeks after birth, both in premature and 
term neonates5. Low MBL concentrations have 
been related to lower gestational age6. Therefore, 
low MBL concentrations may not only be explained 
by MBL2 gene mutations, but also by prematurity7 . 
So, we aimed to evaluate the levels of MBL in 
premature neonates and to determine the relation 





This prospective case control study was conducted 
on 64 neonates, as a stratified non random sample, 
enrolled from neonatal intensive care units of 
Obstetric and Gynecology Hospital, Ain Shams 
University and El-Matareya Teaching Hospital 
during the period from June 2008 to November 
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2008. An informed consent was taken from the 
parents before their enrollment in the study. 
Neonates were divided into 2 groups: 
The study group: It included 39 preterm 
neonates, 32 males and 7 females with gestational 
ages less than 36 weeks and they were classified 
into two groups, septic group and non septic group 
according to sepsis score8. The control group 
included 25 healthy full term neonates, 11 males 
and 14 females appropriate for gestational age (FT-
AGA). 
Exclusion criteria: Neonates were excluded 
from the study if they had: 
- History of maternal fever and chorioamnionitis. 
- Congenital malformation. 
- Chromosomal abnormalities. 
- Premature rupture of membranes (PROM)>18 
hours. 
Careful history was taken including maternal, 
obstetric, and perinatal history. In addition, full 
clinical examination, birth weight measurement, and 
gestational age assessment were done. 
Laboratory investigations: 
Blood samples were withdrawn from all neonates by 
venipuncture within the first 24 hours of admission, 
and cord blood samples were withdrawn from 17 of 
them in the delivery room (10 samples from preterm 
neonates and 7 from full term neonates). 
1. Two mL venous blood/ cord blood were collected 
in a plain tube and were allowed to clot for 30 min 
to estimate MBL serum level by ELISA technique 
(Sanquin Reagents, Plesmanlaan 125, 1066 CX 
Amsterdam, The Netherlands). Samples were then 
centrifuged at 3000 rpm for 10 min. The supernatant 
was separated in aliquots and stored at -20°C until 
time of assay. 
MBL serum level ≤0.7 µg/ml was considered 
deficient; an optimal cut-off plasma level for MBL 
deficiency was 0.7 µg/ml7. 
2. Three mL venous blood were collected 3 days 
after birth, 1 week after birth and when indicated 
and divided as follows: 
a) Two mL were collected on K-EDTA tube for 
CBC analysis and were immediately analyzed on 
Coulter Counter Gen (Coulter Electronics 
Corporation Hielach, Florida, USA). Differential 
leucocytic count was done on Leishman stained 
peripheral blood smear. 
b) One mL was collected and was immediately 
analyzed for CRP with titer analysis by latex 
agglutination test. (Kit provided by Teco 




 Statistical Methods 
Data were analyzed using Statistical Package 
for Special Science (SPSS) software computer 
program version 13. Quantitative data were 
described using mean ± standard deviation, median 
(interquartile range); qualitative data were described 
in the form of numbers and percentages. Student t- 
test of two independent samples was used for 
comparison of normally distributed quantitative 
variables while Mann-Whitney test was used for 
non- parametric data. Chi-square test was used for 
comparison of qualitative variables. Wilcoxon 
signed rank test was used to compare follow up with 
initial values. Correlation between continuous 
variables was performed using Spearman correlation 
coefficient (r). The relative contribution of some 
variables to the risk of MBL deficiency was 
expressed as the OR with a 95% confidence interval 
(CI).   
 
RESULTS 
The demographic and clinical characteristics of 
studied neonates are listed in table (1). The study 
group included 39 preterm neonates with mean 
gestational age 32.97±2.12 weeks and mean birth 
weight 1.89±0.54 kg. The control group included 25 
fullterm neonates with mean gestational age 
39.04±1.27 weeks and mean birth weight 3.2±0.4 
kg. There was a highly significant difference in 
gestational age and birth weight between both 
groups and a significant difference in gender. 
A highly significant decrease in Apgar scores at 
1 and 5 minutes was found in preterm group, and no 
significant difference between both groups in mode 
of delivery and number of neonates whose mothers 
had PET. 
Mean MBL serum level was found to be 
insignificantly lower in preterm than full term 
neonates (p=0.058). (Table 2). 
A negative correlation albeit an insignificant 
one, was detected between MBL plasma level of 
neonates of the preterm group and their gestational 
ages (r = - 0.116, p>0.05), while there was a highly 
significant negative correlation between their MBL 
serum level and their birth weights (r = - 0.447, 
p<0.01). An insignificant positive correlation was 
detected between MBL serum level of preterm and 
fullterm neonates together with their gestational 
ages (r = 0.149, p>0.05) and birth weights (r = 
0.035, p>0.05). 
Fifteen patients of our preterm group developed 
sepsis after the first week of life. On comparing the 
septic and nonseptic groups, there was no 
significant difference as regards the MBL serum 
level. (Table 3). However 50 % of preterms with 
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MBL levels ≤0.7µg/ml (deficient in MBL) 
developed sepsis in the face of 26.3 % only in the 
non deficient group (those with MBL levels 
>0.7µg/ml), although the difference was not 
significant (p>0.05). (Figure 1). 
A highly significant positive correlation was 
demonstrated between MBL serum level in 
neonatal and umbilical cord blood samples. (Figure 
2). 
On estimating the different risk factors which 
may affect the MBL serum level, gestational age 
(<37 weeks), birth weight (<1500 gm), preterm 
neonates with RDS, gender, mothers with 
preeclampsia, and mode of delivery, all were found 
to have insignificant effects. (Table4). 
 
Table 1. Demographic data of study (preterm) and control (full term) groups. 
Variable Preterm n=39 
Fullterm 
n=25 P value 
Gestational Age (Wks) 
(mean ± SD) 
28 – 36 
32.97 ± 2.12 
37 – 42 
39.04 ± 1.27 
0.000** 
Birth Weight (kg) 
(mean ± SD) 
1.0 – 3.0 
1.89 ± 0.54 
2.7 – 4.0 
3.2 ± 0.4 
0.000** 
Male / Female 32 / 7 11 / 14 0.002* 
SVD / LSCS  16 / 23 12 / 13 0.58 
APGAR at 1 min 
               
                at 5 min  
3 – 6 
5.13±0.69 
6 – 9 
8.33±0.73 
5 – 7 
6.04±0.45 





PET (%) 7 (17.9%) 2 (8%) 0.26 
No RDS 
RDS grade II 
                   III 








SVD: Spontaneous Vaginal Delivery, LSCS: Lower Segment Caesarean 
Section, PET: Preeclamptic toxemia, RDS: Respiratory Distress Syndrome,     
** Highly Significant,   * Significant 
 
 
Table 2. Comparison of MBL serum level between preterm and full term neonates. 
MBL level in neonatal 






Range 0.1 – 2.8 0.2 – 6.5 
Mean ± SD 1.06 ± 0.79 2.12 ± 2 0.058 













chi square = 2.31, p>0.05  
 
Figure 1. Comparison between MBL deficient and MBL non deficient preterm neonates as 
regards development of sepsis. 
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Table 3. Comparison between septic and non septic groups of 
preterm neonates as regards MBL serum level. 
Preterm group n MBL level (µg/ml) P value 
Range 0.1 - 2.4 Non septic group 24 Mean ± SD 1.146 ± 0.79 
Range 0.1 - 2.8 Septic group 15 Mean ± SD 0.933 ± 0.82 
0.33 
(P>0.05) 
MBL: Mannose binding lectin 
 
 
Table 4. Association of different factors with risk of MBL deficiency 
95% CI of odds ratio Variable Odds ratio 
Lower  upper 
GA 2.237 0.784 6.386 
BW 0.278 0.067 1.147 
RDS 1.250 0.280 5.585 
PET 0.333 0.075 1.475 
Sex 1.413 0.487 4.100 
Delivery 0.723 0.266 1.969 
GA: gestational age, BW: birth weight, RDS: respiratory 
distress syndrome, PET: preeclamptic toxaemia       
 





















































 r =0.88, p<0.01 
Figure 2. Correlation between MBL serum level in neonatal and umbilical cord samples. 
 
DISCUSSION 
In neonates, low MBL levels are associated not 
only with variant MBL2 genotype, but also with 
low gestational age. Detection of MBL deficiency 
at birth should be based on actual MBL plasma 
levels rather than on MBL2 genotype7. This was 
concluded by van der Zwet et al.9, they 
demonstrated that there was no relationship 
between MBL genotype and the risk of nosocomial 
sepsis or pneumonia, even after correction for birth-
weight, because of an insufficient correlation 
between genotype and the concentration of 
functional MBL. 
In the present study, the first day MBL level 
was found to be lower in preterm group (mean 
MBL=1.06 µg/mL) when compared to the full term 
group (mean MBL=2.12 µg/mL). Yet this 
difference was not statistically significant. This 
could be explained by the fact that only 10 of our 
preterm patients were less than 32 weeks, and some 
studies as the study done by de Benedetti et al.10 
demonstrated that MBL levels were related to 
gestational age. Neonates with GA>32 weeks had 
MBL levels significantly higher than those with 
GA<32 weeks. So, they concluded that low MBL 
levels in neonates may also be secondary to a 
maturational defect; possibly involving the liver 
secretory capacity i.e. prematurity is associated 
with insufficient MBL production by the liver. 
MBL deficiency in preterm neonates 
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Our results were in agreement with those of 
Frakking et al.7, who demonstrated no statistical 
significant difference between preterm and full term 
groups regarding MBL levels. 
Also, we have found that MBL levels in 
preterm neonates alone or together with fullterm 
neonates were not significantly correlated with 
gestational age. Other researchers found this 
relationship significant7,11. The finding in this study 
of a significant negative correlation of MBL with 
birth weight in the preterm group was contradictory 
with another study which demonstrated that MBL 
level was not affected by birth weight suggesting 
that small for gestational age preterm neonates have 
similar MBL levels to appropriate for gestational 
age preterm neonates6. 
Various factors were tested to determine which 
was more influential on MBL level and it was 
found that gestational age, birth weight, RDS, PET, 
gender, and mode of delivery were all non-
significant. It is to be noted that in our study an 
optimal cut off serum level for MBL deficiency was 
0.7 µg/mL, while in the studies of Lau et al6 and 
Ozdemir et al.12, the cut off value was 0.4 µg/mL. 
Analysis of our results revealed that 50 % of 
the MBL deficient preterm neonates and 26.3 % of 
the MBL non deficient preterm neonates developed 
sepsis, yet this difference was not statistically 
significant. Some studies like ours did not find an 
increased sepsis risk in neonates with low MBL 
levels11. Also on comparing the septic and 
nonseptic groups, the lower mean MBL level of the 
septic group was not statistically significant. This 
could be explained on the basis that the number of 
the neonates in the study group was small. A larger 
scale study would give a better insight on the 
relation of MBL to sepsis. Furthermore 
development of sepsis is multifactorial in which 
many deficiencies besides that of MBL come into 
play. 
In a study done to outline the role of MBL in 
determining the susceptibility of preterm neonates 
to severe sepsis, cord blood MBL was measured in 
44 preterm neonates and was found to be 
significantly lower in neonates who developed  
sepsis than those who did not develop sepsis12. 
In another study, the plasma levels of MBL 
were determined at birth in 88 neonatal intensive 
care patients (71 premature). Thirty-five neonates 
(40%) had low, i.e. ≤0.7 µg/ml, MBL plasma levels 
at birth. The authors concluded that MBL 
deficiency increases the susceptibility to infections 
in premature and term NICU-patients. The presence 
of low (≤0.7 µg/ml) MBL plasma levels at birth 
appeared to be associated with early onset sepsis 
(EOS). In addition, neonates with low MBL plasma 
levels appeared to have an increased risk of severe 
infections during the first month of life compared to 
neonates with normal plasma levels13. 
There is a report of an increased risk of 
nosocomial sepsis with low MBL levels at birth in a 
cohort of 206 neonates admitted to NICU. The 
authors suggested that MBL is protective against 
the development of neonatal sepsis10,14. In a study 
done to investigate the association between serum 
MBL levels and development of sepsis in neonates, 
the authors demonstrated that high serum MBL 
levels protect from sepsis independent of 
gestational age or birth weight10.  
The combination of prematurity and low MBL 
levels increases the risk of sepsis to 70%14. This is 
because low MBL levels might be associated with 
decreased capacity of phagocytosis or opsonization 
of microorganisms13. Binding of MBL to Staph. 
aureus was found to be markedly impaired at 
concentrations of  <0.6 µg/ml15. 
In the current study, 17 paired first day neonatal 
and umbilical cord samples showed highly 
significant correlation in their MBL level (r = 0.88). 
A similar correlation was reported by Frakking et 
al.7 (r = 0.95). Therefore, umbilical cord blood can 
be used to detect MBL deficiency as umbilical cord 
sampling is easier and less invasive than venous 
puncture in neonates7. 
In conclusion, premature neonates tend to have 
low MBL serum concentrations which could be 
measured in either their venous or umbilical cord 
blood efficiently. A higher percentage of preterm 
neonates deficient in MBL develop sepsis. 
Further studies are needed to investigate the 
relationship between MBL deficiency and neonatal 
sepsis and whether measuring MBL levels might be 
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